Sree Rayalaseema Hi-Strength Hypo Ltd consolidated sales up 29.31% on year in Q2FY2026, net profit saw a strong growth of 23.28%,
Sree Rayalaseema Hi-Strength Hypo Ltd share price ticked higher by 0.06% to Rs 499.85 after the company`s net profit soared by 23.28% to Rs 24.73 crore, while revenue from operations increased sharply by 29.31% to Rs 210.95 crore in Q2FY26 over Q1FY26. The market capitalization of Commodity Chemicals industry group stocks on BSE stood at Rs 1.65 lakh crore, rising 9.93%. It has eased by 1.74% over last one week and eased lower by 0.58% in last one month while the market capitalization of Sree Rayalaseema Hi-Strength Hypo Ltd has improved by 1.73% and 0.31% in the same period respectively. Profit before tax (PBT) of Sree Rayalaseema Hi-Strength Hypo Ltd stood at Rs 33.9 crore in Q2 FY26, gaining 8.20% year-on-year, and rallying 44.75% quarter-on-quarter. EBITDA came in at Rs 20 crore, rising by 14.03% YoY and plunging by 533.62% sequentially. Total expenses surged 20.60% to Rs 182.9 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 114.0 crore, soaring by 36.17% YoY, while employee benefits expense was at Rs 10.22 crore, tanking by 37.03% YoY. For the TTM ended FY26, revenue from operations tumbled 26.35% to Rs 637.82 crore, while net profit rose by 10.76% to Rs 87.47 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 8414% to Rs 52.58 crore, and PBT improved 11.06% to Rs 119.15 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 65.48 crore in FY26, as against Rs 139.69 crore in FY25. Sree Rayalaseema Hi-Strength Hypo Ltd crashed 17.80% in last one year, underperforming the benchmark BSE Sensex which has slipped by 3.04% during the same period.
Sree Rayalaseema Hi-Strength Hypo to discuss results,
Sree Rayalaseema Hi-Strength Hypo will hold a meeting of the Board of Directors of the Company on 12 August 2026.
Board of Sree Rayalaseema Hi-Strength Hypo recommends final dividend,
Sree Rayalaseema Hi-Strength Hypo announced that the Board of Directors of the Company at its meeting held on 30 May 2026, inter alia, have recommended the final dividend of Rs 3 per equity Share (i.e. 30%) , subject to the approval of the shareholders.
Sree Rayalaseema Hi-Strength Hypo consolidated net profit declines 8.78% in the March 2026 quarter,
Net profit of Sree Rayalaseema Hi-Strength Hypo declined 8.78% to Rs 20.06 crore in the quarter ended March 2026 as against Rs 21.99 crore during the previous quarter ended March 2025. Sales rose 1.66% to Rs 163.14 crore in the quarter ended March 2026 as against Rs 160.48 crore during the previous quarter ended March 2025.For the full year,net profit rose 3.06% to Rs 90.15 crore in the year ended March 2026 as against Rs 87.47 crore during the previous year ended March 2025. Sales rose 4.57% to Rs 666.96 crore in the year ended March 2026 as against Rs 637.82 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales163.14160.48 2 666.96637.82 5 OPM %8.1510.98 -13.2614.43 - PBDT30.7732.26 -5 141.59129.53 9 PBT28.9530.36 -5 134.35122.21 10 NP20.0621.99 -9 90.1587.47 3 Powered by Capital Market - Live News
Sree Rayalaseema Hi-Strength Hypo schedules board meeting,
Sree Rayalaseema Hi-Strength Hypo will hold a meeting of the Board of Directors of the Company on 30 May 2026.
Subscribe for our
newsletter
Open Account Now